Result of AGM

Summary by AI ^BETAClose X

Iofina plc announced that all resolutions proposed at its 2026 Annual General Meeting were duly passed, with strong shareholder support for the Annual Report and Accounts (99.98% for), the reappointment of directors Mary Fallin Christensen (99.25% for) and Tim Hughes (99.68% for), the reappointment of auditors UHY Hacker Young LLP (99.99% for), and the authorization for directors to allot shares (99.19% for) and make market purchases of shares (99.60% for). Shareholder approval was also received for empowering directors to allot shares without a pro-rata offer (97.33% for) and for the Share Option Plan (99.13% for).

Disclaimer*

Iofina PLC

09 June 2026

9 June 2026

Iofina plc

("Iofina" or the "Company")

(AIM: IOF)

Result of AGM

Iofina plc, manufacturers of specialty chemical products and specialists in the exploration and production of iodine, held its 2026 Annual General Meeting ("AGM") earlier today.

All resolutions proposed at the AGM, as set out in the Notice of Meeting dated 5 May 2026, were duly passed.

The table below shows the proxy position of all resolutions:

RESOLUTIONS	FOR (and including at discretion)		AGAINST		WITHHELD
Total votes cast: 83,005,053	No. of votes	%	No. of votes	%	No. of votes
Resolution 1 To receive and approve the Annual Report and Accounts for the year ended 31 December 2025	82,992,353	99.98%	2,000	0.01%	10,700
Resolution 2 To reappoint Mary Fallin Christensen as a director	82,375,954	99.25%	626,296	0.75%	2,803
Resolution 3 To reappoint Tim Hughes as a director	82,478,434	99.68%	262,046	0.32%	264,573
Resolution 4 To reappoint UHY Hacker Young LLP as auditors and to authorise the directors to determine their remuneration	82,989,536	99.99%	8,014	0.01%	7,503
Resolution 5 To unconditionally authorise the Directors to allot shares	82,335,884	99.19%	669,095	0.81%	74
Resolution 6 To empower the Directors to allot shares without first offering them to existing shareholders on a pro-rata basis	80,786,040	97.33%	2,218,968	2.67%	50
Resolution 7 To unconditionally authorise the Company to make market purchases of shares	82,670,953	99.60%	334,100	0.40%	0
Resolution 8 To approve the Share Option Plan	82,263,854	99.13%	719,819	0.87%	21,380

Enquiries:

Dr. Tom Becker

CEO & President

Iofina plc

Tel: +44 (0)20 3006 3135

Nomad & Broker:

Canaccord Genuity Limited

Henry Fitzgerald-O'Connor / Harry Rees

Tel: +44 (0)20 7523 8000

Media Contact:

Yellow Jersey PR Limited

Charles Goodwin / Shivantha Thambirajah / Maya Brookes

Tel: +44 (0)7747 788221 / +44 (0)7983 521488

About Iofina:

Iofina plc (AIM: IOF) is a vertically integrated company that specialises in the production of Iodine and the manufacturing of specialty chemical products. Iofina is the second largest producer of iodine in North America and operates the manufacturing entities Iofina Resources and Iofina Chemical.

LEI: 213800QDMFYVRJYYTQ84

ISIN: GB00B2QL5C79

Iofina Resources

Iofina Resources develops, builds, owns, and operates iodine extraction plants using Iofina's WET® IOsorb® technology. Iofina currently operates six producing IOsorb® plants in Oklahoma and is consistently using technology and innovation to improve and expand its operations.

Iofina Chemical

Iofina Chemical has manufactured high quality halogen speciality chemicals derived from raw iodine, as well as non-iodine-based products. Iofina Chemical celebrated its 40^th anniversary in 2023 as a preeminent halogen-based specialty chemicals company.

www.iofina.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END